fragment and sequence peptides from the most abundant chromatography peaks, leading to infrequent and stochastic detection of lowly abundant peptides. This leads to incomplete sampling in large-scale datasets containing many samples, making it impossible to distinguish between missing measurements due to stochastic detection verses the true absence of a peptide of interest [21] .
To comprehensively quantify protein dynamics across various chromatin environments, we developed Chromatin Enrichment by Salt Separation followed by Data-Independent Acquisition (ChESS-DIA) (Supplementary Figure 1) . Protein-nucleic acid interactions are largely driven by electrostatic attraction [22] , and by treating isolated nuclei with increasing salt concentrations, we observe a bimodal disruption and release of proteins from surrounding nuclear material (Supplementary Figure 2) . As previously reported, this bimodality reflects differences in the physical characteristics of open regions of "active" euchromatin versus "closed" heterochromatin in the nucleus [22] . We leverage these differences to combine a facile, scalable nuclear separation protocol followed by label-free data-independent mass spectrometry acquisition, allowing the comprehensive isolation and chromatin environment assignment for greater than 70% of the proteins predicted to be expressed in the nuclear proteome. In short, nuclei are isolated from cells or tissue of interest, then subjected to a series of extraction conditions that isolate (1) unbound proteins in the nucleoplasm, (2) proteins bound in accessible euchromatin, (3) bound in heterochromatin and (4) insoluble structural proteins. This insoluble fraction, which primarily contains histones and lamina-associated proteins, accounts for a large fraction of the ions measured in a typical nuclear extraction, so their separation from functional chromatin compartments allows for more comprehensive sampling of proteins in euchromatin and heterochromatin. After protein extraction, digestion and desalting, mass spectrometry data is acquired and quantified using on-column chromatogram libraries to increase sensitivity and reproducibility across large datasets [23] (Supplementary Figure 1) .
We compared ChESS-DIA with a recently published high-quality nuclear proteomics dataset in an acute myeloid leukemia cell line that utilizes TMT-isobaric mass tagging [24] .
Overall, ChESS-DIA detected 33% more TFs and cofactors, and this improvement is dependent on TF family. For example, important developmental TF families that tend to be lowly expressed, such as homeodomains and forkhead proteins, are detected at a 2-fold and 1.8-fold higher rate, respectively. Proteins detected by ChESS-DIA had good peptide coverage, with a median value of 5.5 peptides per protein ( Figure 1C ). Peptide detection rates generally correlated with protein expression level, and <2% of peptides were detected for genes unlikely to be expressed ( Figure   1D , RNA-seq FPKM < 1.0). Gene Ontology (GO) enrichment analysis of the observed proteins show high enrichment scores for annotations related to nucleic acid binding, chromatin regulation and nuclear localization. Among the chromatin compartments, euchromatin shows the strongest GO enrichment (Supplementary Figure 3) .
To further validate chromatin compartments extracted with this method, we observed the distributions of several protein complexes with well-established roles in a defined chromatin context ( Figure 1D ). The exportin family of proteins that regulate nuclear export and the RISC RNA-processing complex are highly enriched in the nucleoplasm, consistent with their nonchromatin related function. The transcriptional coactivating mediator complex is found predominantly in the euchromatin fraction [25] , as is the SWI/SNF chromatin remodeler. The SWI/SNF complex can facilitate the transition of polycomb-repressed regions into accessible euchromatin, and interestingly, subsets of the SWI/SNF associated peptides are also found to occupy heterochromatin compartments by ChESS-DIA, particularly peptides mapping to the catalytic subunits SMARCA2 and SMARCA4 [26] . Centromeres, a canonical heterochromatin structure, are highly enriched in this fraction, as are proteins associated with the nucleolus.
Histones and nuclear lamina are predominantly insoluble, with the exception of LAP2A, which is a lamina-family protein with an established role regulating gene expression in euchromatin [27] .
TFs are found to occupy all four fractions, as expected by their wide range of functionalities within the nucleus ( Figure 1E ). Nucleoplasmic TFs include NFkB, which is sequestered from chromatin until an activating phosphorylation event. The euchromatic TFs include many lineagespecific and oncogenic TFs that known to dominate the transcriptional regulatory program in K562 cells [28] . Heterochromatic TF include proteins with known roles in nuclear organization (CTCF), interaction with methylated DNA (MECP2, MBD1) and chromatin compaction [29] . Insoluble TFs notably include many zinc finger TFs that constitutively suppress retrotransposon activity [30] .
We validated the ChESS-DIA quantification using cellular immunofluorescence (IF) imaging as an orthogonal method of protein quantification. Analysis of extraction kinetics for the euchromatic GATA1 TF shows rapid and complete removal from nuclei after a 5-minute extraction (Figure 2A ), quantified across 100 cells per time point ( Figure 2B ). All TFs studied were completely extracted after 10 minutes (data not shown). All subsequent proteomics data presented in this study employ 20 minute extractions to account for the potential variability in proteome-wide extraction kinetics. IF was then performed on canonical members of each chromatin compartment assayed ( Figure 2C ). Single-cell IF quantification of TF extractions show a striking correlation with ChESS-DIA based quantification across all fractions. This is even reflected for the BRD4 protein is present in both the euchromatin and heterochromatin fraction, which is reflected in the IF-based quantification. Furthermore, we integrated ChESS-DIA compartment assignments with the large-scale effort to map subcellular locations by IF performed by the Human Protein Atlas (HPA) [31] . The three chromatin-bound fractions, as defined by ChESS-DIA, are only enriched in nuclear-related subcellular locations by IF. ChESS-DIA euchromatin proteins are most likely to be assigned within nuclear speckles, which contain splicing factors and are involved in active transcription within the nucleus [31] . ChESS-DIA insoluble proteins, on the other hand, are most likely to be found associated with the nuclear membrane, consistent with the role of membrane sequestration in gene silencing [31] .
With a validated method in hand, we turned to address a longstanding problem in the pharmacodynamics of transcriptional regulators. Transcriptional regulatory proteins that lack a catalytic domain are often difficult to drug with small molecule inhibitors, but the development of heterobifunctional small molecule compounds that can bind and degrade their target protein effectively target this protein class [24, 33] . The primary pharmacodynamic effect of these compounds is a global reorganization of chromatin, but this is difficult to measure with ChIP-based methods or existing nuclear proteomics methods, obfuscating the full effects of these compounds.
Therefore, we applied ChESS-DIA to characterize the global chromatin response to acute degradation of the first reported pharmacological degraders that target the BET bromodomains.
The BET bromodomain family contains BRD2, BRD3, BRD4 and BRDT, all which contain tandem bromodomains that function to bind acetylated lysine residues on histones and transcription factors [34, 35] . They are expressed constitutively across all tissues and they play important roles in gene regulation and nuclear organization [36] . Furthermore, their function is implicated in many models of human cancer and drugs targeting BETs are currently in clinical investigation for various tumor types [37] . In steady-state cells, BRD2, BRD3 and BRD4 contain partially overlapping but distinct chromatin compartment distributions ( Figure 3A ), consistent with their partially overlapping but distinct roles in transcriptional regulation [38] [39] [40] .
Recently, dBET1 was developed as a first-in-class small molecule BET bromodomain degradation compound [24] . dBET1 functions by selectively binding the BET bromodomain and recruits the cereblon-CUL4 ubiquitin ligase complex, leading to BET ubiquitination and proteasome-mediated degradation. In agreement with previously published measurements of dBET1 kinetics [32] , ChESS-DIA confirmed the depletion of total BRD2, BRD3 and BRD4 from all chromatin compartments within 2 hours of treatment with dBET1 in MOLM-13 acute myeloid leukemia cells. BRDT is a testes-specific protein and is not expressed in these cells. We then looked specifically at the euchromatin protein fraction, where canonical BET bromodomain cofactors are observed. During dBET1 treatment, CDK9 (pTEFb) and the mediator complex are lost from euchromatin, consistent with previous studies showing loss of these transcriptional cofactors upon loss of BET bromodomains from chromatin as measured by ChIP-seq [41] . Protein subunits of RNA PolII are also depleted from active chromatin, consistent with a global loss in transcriptional activity ( Figure 3C ) [42] .
Looking across all fractions, we observed a striking reorganization of HDAC1 and HDAC2 peptides from euchromatin into heterochromatin with the same kinetics as BET bromodomain loss. HDAC1/2 cooperate as part of the NuRD complex to regulate transcription by deacetylating acetylated histones and promoting chromatin compaction, particularly at bivalent genes during development [43] . Peptides for the other NuRD complex members show the same pattern of euchromatin to heterochromatin transition ( Figure 3E ), so we hypothesized that this phenomenon was due to chromatin compaction at sites shared by HDAC1/2 and BETs. Indeed, like the BET bromodomains and their cofactors, HDAC1/2 are found predominantly euchromatin ( Figure 3F ).
To test for genome-wide co-occupancy of HDAC1/2 and BET bromodomains, we used Cut&Run to map binding locations of all factors [44] . Indeed, HDAC1/2 Cut&Run peaks display significant overlap with BRD2 (18% of HDAC1/2 shared peaks), BRD3 (5%) and BRD4 (11%). These findings support a model where at steady-state, HDAC1/2 activity is suppressed at active DNA regulatory elements by BET bromodomains. When the BETs are degraded by dBET1, HDAC1/2 complexes remaining at regulatory DNA can deacetylate nearby histones, leading to compaction local chromatin after BET loss ( Figure 3G ).
In summary, ChESS-DIA is a facile, robust and scalable assay to measure nuclear protein dynamics across different chromatin environments. Chromatin environments observed in ChESS-DIA correspond to historically-defined functional chromatin fractions defined in the literature and correlate with imaging-based chromatin environments as defined by IF. We applied this method to study the small molecule degrader dBET1 and provide the first description of the chromatinwide effects of a PROTAC compound, highlighting a previously unknown interaction between BET bromodomains and histone deacetylase protein complexes. We expect ChESS-DIA to aid provide a new approach to study all nuclear processes that undergo post-transcriptional dynamic regulation. The pellet contains the insoluble protein fraction.
Methods

Cell
Protein Preparation and Digestion
Protein samples were supplemented with 0.1% PPS silent surfactant, and the chromatin pellet was sonicated at power 5 for 10s to solubilize proteins. All samples were then boiled at 95°C for 5 minutes, reduced with 5mM DTT at 60°C for 30 minutes and alkylated with 15mM iodoacetic acid (IAA) at 25°C for 30 minutes in the dark. Proteins were then digested with Trypsin (Promega) at 37°C for 2 hours while shaking (1:20 trypsin:protein per sample) and the pH of the sample was subsequently adjusted to <3.0 using HCl. The digested samples were desalted using Oasis MCX 30 mg/60 μm cartridges (Waters) following the manufacturer's protocol with minor modifications. Briefly, the cartridge was conditioned using 1 mL methanol, 1 mL 10% ammonium hydroxide in water, 2 mL methanol and finally 3 mL 0.1% formic acid in water. The samples were then loaded onto the cartridge and washed with 1 mL 0.1% formic acid in water and 1 mL of 90% acetonitrile in water. The peptides were eluted from the cartridge with 1 mL 10% ammonium hydroxide in methanol which was then removed by evaporation. Peptide samples were resuspended to a concentration of 1ug/3μl in 0.1% formic acid in H2O and stored at -20°C until injected on the mass spectrometer.
Mass Spectrometry Acquisition
Peptides were separated with a Waters NanoAcquity UPLC and emitted into a Thermo Q-Exactive HF. Pulled tip columns were created from 75 μm inner diameter fused silica capillary in-house using a laser pulling device and packed with 3 μm ReproSil-Pur C18 beads (Dr. Maisch) to 300 mm. Trap columns were created from 150 μm inner diameter fused silica capillary fritted with Kasil on one end and packed with the same C18 beads to 25 mm. Solvent A was 0.1% formic acid in water, while solvent B was 0.1% formic acid in 98% acetonitrile. 
Mass Spectrometry Data Analysis
Thermo RAW files were converted to .mzML format using the ProteoWizard package (version 3.0.7303) where they were peak picked using vendor libraries and deconvoluted using Prism in "overlap_only" mode. Narrow-window DIA experiments were searched with XCorDIA (manuscript in preparation) using a Human Uniprot protein FASTA file (downloaded 06/10/2017) as both the target and background database. +1H to +4H peptides were detected using default settings (10 ppm precursor and fragment tolerances, trypsin digestion with up to one missed cleavage), assuming fixed cysteine carbamidomethylation. These peptide detections were combined into a chromatogram library, which was used for further processing. EncyclopeDIA was configured to search the wide-window DIA experiments against this chromatogram library with default settings 2D cell images were acquired using an inverted Nikon Eclipse Ti widefield microscope equipped with a 40x Nikon Plan Apo 0.9 NA air objective and an Andor Zyla 4.2CL10 CMOS camera with a 4.2-megapixel sensor and 6.5μm pixel size (18.8mm diagonal FOV). Acquired images were subject to 3 rounds of iterative blind deconvolution using Autoquant software (version X3.3, Media Cybernetics, NY) to minimize the effect of out-of-focus blurring that is inherent to widefield microscopy optics. Deconvolved images were processed using custom morphometric analysis software to yield numerical estimates for nuclear size and normalized protein content in every cell nucleus.
Cut & Run
Cut & Run was performed as described previously [44] with minor alterations. 100,000 K562 cells were used per condition. The following antibodies were used:
• BRD2: Active Motif 61797
• BRD3: Active Motif 61489
• BRD4: Bethyl BL-149-2H5
• HDAC1: Active Motif 40967
• HDAC2: Active Motif 39533
After digestion, underwent library preparation with ThruPLEX DNA-seq kit and sequenced on the NextSeq 500 platform (Illumina). Reads were aligned to the human genome (hg38 build) using BWA (version 0.7.12) [48] and peaks called with MACS2 [49] using a q-value cutoff of 0.01. 
